Literature DB >> 19471113

Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression.

Zhiming Hao1, Xiaohua Li, Taidong Qiao, Shuang Li, Yifei Lv, Daiming Fan.   

Abstract

Our previous studies revealed that cytokine induced apoptosis inhibitor 1 (CIAPIN1), which was reported to be essential in mouse definitive hematopoiesis, was related to multidrug resistance in gastric cancer cells and that the distribution of CIAPIN1 in normal human tissues was similar to the distribution of Ras. This study aimed to explore whether CIAPIN1 plays a role in gastric carcinogenesis. Expression of CIAPIN1 in normal, inflammatory gastric mucosa, gastric precancerous lesions and gastric adenocarcinoma was detected by immunohistochemistry and western blotting and, influence of CIAPIN1 on the proliferation of gastric cancer cells was investigated by ectopic expression of CIAPIN1 and RNA interference (RNAi). Our immunohistochemical results demonstrated that the expression of CIAPIN1 in gastric antral mucosa was progressively reduced along the sequence of normal/inflammatory gastric mucosa-atrophy-intestinal metaplasia-dysplasia-adenocarcinoma. The downregulation of CIAPIN1 in cancerous tissues was further confirmed by western blotting. No relationship between the expression level of CIAPIN1 and the clinicopathological parameters such as age, gender, differentiation, TNM stage and the existence of metastasis was found in gastric cancer patients. In in vitro cellular experiments, ectopic expression of CIAPIN1 by cDNA transfection resulted in suppression of cell proliferation and inhibition of cell cycle progression while knockdown of CIAPIN1 with siRNA accelerated cell proliferation and promoted cell cycle progression in SGC7901 and MKN28 gastric cancer cells. These results suggest that downregulated CIAPIN1 expression may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471113     DOI: 10.4161/cbt.8.11.8796

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  5 in total

1.  Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Authors:  Hai Shi; Yi Zhou; Heliang Liu; Changsheng Chen; Shujun Li; Nanlin Li; Xiaohua Li; Xi Zhang; Hongwei Zhang; Weizhong Wang; Qingchuan Zhao
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

2.  Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics.

Authors:  C Y X'avia Chan; John C McDermott; K W Michael Siu
Journal:  Int J Proteomics       Date:  2011-03-29

3.  Down regulation of CIAPIN1 reverses multidrug resistance in human breast cancer cells by inhibiting MDR1.

Authors:  Dan Lu; Zhibo Xiao; Wenxiu Wang; Yuqing Xu; Shujian Gao; Lili Deng; Wen He; Yu Yang; Xiaofei Guo; Xuemei Wang
Journal:  Molecules       Date:  2012-06-20       Impact factor: 4.411

4.  The significance of LRPPRC overexpression in gastric cancer.

Authors:  Xiaosa Li; Lifen Lv; Jianyong Zheng; Jinfeng Zhou; Bing Liu; Hui Chen; Cong Liang; Rui Wang; Linna Su; Xiaohua Li; Daiming Fan
Journal:  Med Oncol       Date:  2013-12-28       Impact factor: 3.064

5.  Progesterone receptor membrane component 1 is involved in oral cancer cell metastasis.

Authors:  Hsun-Yu Huang; Hsiu-Chuan Chou; Ching-Hsuan Law; Wan-Ting Chang; Tzu-Ning Wen; En-Chi Liao; Meng-Wei Lin; Li-Hsun Lin; Yu-Shan Wei; Yi-Ting Tsai; Hsin-Yi Chen; Kui-Thong Tan; Wen-Hung Kuo; Mei-Lan Ko; Shing-Jyh Chang; Ying-Ray Lee; Hong-Lin Chan
Journal:  J Cell Mol Med       Date:  2020-07-16       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.